MICROBA LIFE SCIENCES LIMITED (MAP)

---

AI Coverage Rating: Low

ASX AI Signals has generated 0 signals for MAP during the last 90 days, indicating low trading activity

MAP Share Price
Current Price	$0.039
52 Week High	$0.105
52 Week Low:	$0.036
Trading at (% of 52 Week High)	37.14%

Business Overview

Microba Life Sciences Limited (ASX: MAP) is a biotechnology company specializing in microbiome analysis and research. It provides services and products that help understand the role of the gut microbiome in human health and disease. The company supports healthcare, research, and pharmaceutical sectors with its advanced microbiome testing and data.

ASX Sector Overview

Sector:   Health Care Equipment & Services

The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.

Latest AI Recommendation

Latest  MICROBA LIFE SCIENCES LIMITED(MAP)   News